Raptor Pharmaceutical Corp Capital Expenditures
Raptor Pharmaceutical Corp reported Capital Expenditures of $581.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2016-08-04
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for the quarter ending 2016-06-30 was $274.00K, a 0.37% increase year-over-year.
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for the quarter ending 2016-03-31 was $307.00K, a 84.99% decline year-over-year.
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for the quarter ending 2015-12-31 was $422.00K, a 48.79% decline year-over-year.
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for the quarter ending 2015-09-30 was $150.00K, a 93.20% decline year-over-year.
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for fiscal 2015 was $2.89M, a 43.18% decline from fiscal 2014.
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for fiscal 2014 was $5.09M, a 220.68% increase from fiscal 2013.
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for fiscal 2013 was $1.59M.
- Raptor Pharmaceutical Corp payments to acquire property, plant, and equipment for fiscal 2012 was $385.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 4 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2016-06-30 | $274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $581.00K 10-Q · filed 2016-08-04 | $1.00M derived: sum of 3 quarters · filed 2016-08-04 | $1.15M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2016-03-31 | $307.00K 10-Q · filed 2016-05-05 | $729.00K derived: sum of 2 quarters · filed 2016-05-05 | $879.00K derived: sum of 3 quarters · filed 2016-05-05 | $1.15M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-12-31 | $422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $572.00K derived: sum of 2 quarters · filed 2016-02-26 | $845.00K derived: sum of 3 quarters · filed 2016-08-04 | $2.89M 10-K · filed 2016-02-26 | |
| 2015-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $423.00K derived: sum of 2 quarters · filed 2016-08-04 | $2.47M 10-Q · filed 2015-11-05 | $3.29M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $2.32M 10-Q · filed 2016-08-04 | $3.14M derived: sum of 3 quarters · filed 2016-08-04 | $5.35M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | $2.04M 10-Q · filed 2016-05-05 | $2.87M derived: sum of 2 quarters · filed 2016-05-05 | $5.08M derived: sum of 3 quarters · filed 2016-05-05 | $6.94M derived: sum of 4 quarters · filed 2016-05-05 | |
| 2014-12-31 | $824.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $3.03M derived: sum of 2 quarters · filed 2016-02-26 | $4.90M derived: sum of 3 quarters · filed 2016-02-26 | $5.09M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $4.08M derived: sum of 2 quarters · filed 2015-11-05 | $4.26M 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $2.06M 10-Q · filed 2015-08-06 | |||
| 2014-03-31 | $187.00K 10-Q · filed 2015-05-07 | ||||
| 2013-12-31 | $1.59M 10-K · filed 2016-02-26 | ||||
| 2012-12-31 | $57.00K 10-K · filed 2015-03-02 | ||||
| 2012-08-31 | $385.00K 10-K · filed 2015-03-02 |